Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 24 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Chemotherapy with Echinomycin in Patients with Refractory Small Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-LUN-204 SEG-LUN-204

Last Modified: 4/1/1988


2.		Phase II Chemotherapy with Echinomycin for Advanced Renal Cell Carcinoma (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				UKMC-IRB-29594 NCI-T84-0495R, T84-0495

Last Modified: 4/1/1988


3.		Phase II Chemotherapy with Echinomycin in Patients with Advanced Carcinoma of the Cervix Previously Untreated with Chemotherapy (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-84138A NCI-T85-0002C, T85-0002


4.		Phase II Chemotherapy with Quinomycin-A in Patients with Stage III Bulky Unresectable and Metastatic non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MAOP-2185 MAOP-2185

Last Modified: 8/21/2007


5.		Phase II Chemotherapy with Echinomycin in Patients with Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UKMC-IRB-30085 NCI-T85-0061R, T85-0061


6.		Phase II Chemotherapy with Echinomycin in Patients with non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				UKMC-IRB-29675 NCI-T85-0003R, T85-0003

Last Modified: 5/1/1988


7.		Phase II Chemotherapy with Echinomycin in Patients with Advanced Hormone-Resistant Prostate Cancer (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-85U1 NCI-T85-0170D, T85-0170


8.		Phase III Chemotherapy with Echinomycin in Patients with Metastatic Breast Carcinoma with or without Prior Anthracycline Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over								SEG-BRE-203 SEG-BRE-203

Last Modified: 8/1/1989


9.		Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: Echinomycin (Summary Last Modified 08/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				GOG-26W GOG-26W


10.		Phase II Master Protocol Study of Chemotherapy for Patients with Inoperable, Recurrent, or Metastatic Cancer of the Breast --- Echinomycin

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				CLB-8641 CALGB-8641

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute